Quantitative liver 31P magnetic resonance spectroscopy at 3T on a clinical scanner

Magnetic Resonance in Medicine

Volumn 71, Issue 5, 2014, Pages 1670-1675

  Laufs, Alessandra ^a   Livingstone, Roshan ^a   Nowotny, Bettina ^a   Nowotny, Peter ^a   Wickrath, Frithjof ^a   Giani, Guido ^b   Bunke, Jürgen ^c   Roden, Michael ^a   Hwang, Jong Hee ^a  

^a HEINRICH HEINE UNIVERSITY   (Germany)

^b LEIBNIZ CENTER FOR DIABETES RESEARCH AT HEINRICH HEINE UNIVERSITY DÜSSELDORF   (Germany)

^c PHILIPS HEALTHCARE   (United States)

Author keywords

3T clinical scanner; human liver; molar quantification; phosphorus compounds

Indexed keywords

ADENOSINETRIPHOSPHATE; MAGNETIC RESONANCE; MAGNETIC RESONANCE SPECTROSCOPY; MOLAR CONCENTRATION; PHOSPHATES; PHOSPHORUS COMPOUNDS; SCANNING;

ABSOLUTE QUANTIFICATION; CLINICAL SCANNERS; HIGH SIGNALTO-NOISE RATIOS (SNR); HUMAN LIVER; IN-VIVO SPECTROSCOPY; INORGANIC PHOSPHATES; MOLAR QUANTIFICATION; REPRODUCIBILITIES;

SIGNAL TO NOISE RATIO;

ADENOSINE TRIPHOSPHATE; GLYCEROPHOSPHOETHANOLAMINE; GLYCEROPHOSPHORYLCHOLINE; NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE; PHOSPHATE; PHOSPHOENOLPYRUVATE; PHOSPHORUS 31; URIDINE DIPHOSPHATE GLUCOSE; PHOSPHORUS; RADIOPHARMACEUTICAL AGENT;

ADULT; AGED; ARTICLE; COHORT ANALYSIS; FAT CONTENT; HEPATOGRAPHY; HUMAN; HUMAN TISSUE; IMAGE PROCESSING; NORMAL HUMAN; NUCLEAR MAGNETIC RESONANCE SCANNER; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PHANTOM; SIGNAL NOISE RATIO; DEVICES; FEASIBILITY STUDY; FEMALE; LIVER; MALE; METABOLISM; MIDDLE AGED; OBSERVER VARIATION; PROCEDURES; PROTON NUCLEAR MAGNETIC RESONANCE; REFERENCE VALUE; REPRODUCIBILITY; SENSITIVITY AND SPECIFICITY;

COHORT STUDIES; FEASIBILITY STUDIES; FEMALE; HUMANS; LIVER; MALE; MIDDLE AGED; OBSERVER VARIATION; PHOSPHATES; PHOSPHORUS ISOTOPES; PROTON MAGNETIC RESONANCE SPECTROSCOPY; RADIOPHARMACEUTICALS; REFERENCE VALUES; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY;

EID: 84899421502     PISSN: 07403194     EISSN: 15222594     Source Type: Journal    
DOI: 10.1002/mrm.24835     Document Type: Article

References (26)

1. Szendroedi J, Chmelik M, Schmid AI, Nowotny P, Brehm A, Krssak M, Moser E, Roden M,. Abnormal hepatic energy homeostasis in type 2 diabetes. Hepatology 2009; 50: 1079-1086.
2. 31P MR spectroscopy with proton decoupling. Radiology 2010; 256: 466-473.
3. 31P NMR spectroscopy in diffuse liver disease. Eur Radiol 2005; 15: 148-157.
4. 31P magnetic resonance spectroscopy. Eur J Radiol 2008; 66: 313-320.
5. Dezortova M, Taimr P, Skoch A, Spicak J, Hajek M,. Etiology and functional status of liver cirrhosis by 31P MR spectroscopy. World J Gastroenterol 2005; 11: 6926-6931.
6. Rajanayagam V, Lee RR, Ackerman Z, Bradley WG, Ross BD,. Quantitative P-31 MR spectroscopy of the liver in alcoholic cirrhosis. J Magn Reson Imaging 1992; 2: 183-190.
7. 31P-magnetic resonance spectroscopic imaging. Magn Reson Med 2005; 54: 264-271.
8. 31P metabolites in human liver. Magn Reson Med 2008; 60: 796-802.
9. 31P MRS in vivo. Part II: Muscle, liver, kidney. Magn Reson Med 1994; 32: 453-458.
10. 31P magnetic resonance spectroscopy. NMR Biomed 1990; 3: 17-22.
11. 31P MR spectra acquired at 1.5 and 3.0 Tesla in health and diseased states. NMR Biomed 2011; 24: 231-237.
12. Oberhaensli RD, Galloway GJ, Hilton-Jones D, Bore PJ, Styles P, Rajagopalan B, Taylor DJ, Radda GK,. The study of human organs by phosphorus-31 topical magnetic resonance spectroscopy. Br J Radiol 1987; 60: 367-373.
13. Tosner Z, Dezortová M, TintÄ•ra J, Hájek M,. Application of two-dimensional CSI for absolute quantification of phosphorus metabolites in the human liver. MAGMA 2001; 13: 40-46.
14. Snedecor GW, Cochran WG,. Statistical Methods. 8th ed. Ames, Iowa: Iowa State University Press; 1989.
15. Gruetter R., Automatic localized in vivo adjustment of all first- and second-order shim coils. Magn Reson Med 1993; 29: 804-811.
16. Ordidge R., Connelly A, Lohman JA,. Image-selected in vivo spectroscopy (ISIS). A new technique for spatially selective NMR spectroscopy. J Magn Reson (1969) 1986; 66: 283-294.
17. Machann J, Thamer C, Schnoedt B, Stefan N, Haring H-U, Claussen CD, Fritsche A, Schick F,. Hepatic lipid accumulation in healthy subjects: a comparative study using spectral fat-selective MRI and volume-localized 1H-MR spectroscopy. Magn Reson Med 2006; 55: 913-917.
18. Longo R, Pollesello P, Ricci C, Masutti F, Kvam BJ, Bercich L, Crocè LS, Grigolato P, Paoletti S, De Bernard B,. Proton MR spectroscopy in quantitative in vivo determination of fat content in human liver steatosis. J Magn Reson Imaging 1995; 5: 281-285.
19. 1H MR spectrum. NMR Biomed 2011; 24: 784-790.
20. 31P NMR spectra localized by three-dimensional chemical shift imaging. NMR Biomed 1996; 9: 141-155.
21. Graaf RA de,. In Vivo NMR Spectroscopy: Principles and Techniques. Chichester, UK: John Wiley & Sons; 2008.
22. 31P spectroscopy using the magnetization transfer experiment. NMR Biomed 2008; 21: 437-443.
23. Sijens PE, Dagnelie PC, Halfwerk S, Van Dijk P, Wicklow K, Oudkerk M,. Understanding the discrepancies between 31P MR spectroscopy assessed liver metabolite concentrations from different institutions. Magn Reson Imaging 1998; 16: 205-211.
24. Corbin IR, Ryner LN, Singh H, Minuk GY,. Quantitative hepatic phosphorus-31 magnetic resonance spectroscopy in compensated and decompensated cirrhosis. Am J Physiol Gastrointest Liver Physiol 2004; 287:G 379-384.
25. 31P chemical shift imaging of the human liver. Magn Reson Imaging 1995; 13: 621-628.
26. 31P magnetic resonance spectroscopy. Liver Int 2008; 28: 675-681.